Status:

RECRUITING

Association Between Sarcopenia And Diabetic Neuropathy In Adults With Type 1 Diabetes, A Pilot Study

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

50-80 years

Phase:

NA

Brief Summary

Monocentric interventional prospective study to evaluate the prevalence of sarcopenia in adults with type 1 diabetes (T1DM) and to evaluate the association between diabetic neuropathy and sarcopenia i...

Eligibility Criteria

Inclusion

  • Age 50-80 years, both sexes
  • Diagnosis of T1DM for at least 10 years, in both multiple daily injections of insulin (MDI) and continuous subcutaneous insulin infusion (CSII)
  • Informed consent before any study activity
  • Ability to fully perform all protocol activities

Exclusion

  • Previous diagnosis of T2DM
  • Previous diagnosis of dementia
  • Presence of heart failure (NYHA class III and IV)
  • Presence of muscular disease
  • Diagnosis of neurodegenerative disease (e.g. multiple sclerosis, Parkinson's disease)
  • eGFR evaluated through CKD-EPI formula \<20 ml/min /1.73m2 , estimated on previous creatinine dosage
  • Previous history of stroke or cerebrovascular disease
  • Diagnosis of coeliac disease
  • Diagnosis of chronic inflammatory bowel disease
  • Untreated hypothyroidism or hyperthyroidism or not well controlled hypothyroidism or hyperthyroidism with current therapy (TSH \>5 or TSH \<0.15)
  • Alcohol abuse or consumption of more than 14 alcoholic units weekly
  • Active cancer or therapy
  • Pregnancy
  • Primary hyperparathyroidism
  • Corticosteroid and/or estrogen-progestogen therapy for at least 12 months in medical history
  • On going treatment with antiretroviral therapy
  • On going treatment with immunosuppressive therapy, e.g. cyclosporine, tacrolimus
  • On going treatment with anti-epileptic drugs

Key Trial Info

Start Date :

February 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 31 2026

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06902597

Start Date

February 1 2025

End Date

January 31 2026

Last Update

March 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondazione Policlinico Universitario A. Gemelli IRCCS; UOC Diabetologia

Rome, Lazio, Italy, 00168